The Relation of High Sensitivity C Reactive Protein and Total Leucocytic Count Levels in Threatened Abortion
The Relation Between Maternal Serum High Sensitivity C Reactive Protein and Total and Differential Leucocytic Count Levels in Healthy Pregnant Women With Threatened Abortion and the Outcome of Pregnancy
1 other identifier
observational
240
1 country
1
Brief Summary
to identify the relation between maternal serum high sensitivity C reactive protein and total and differential leucocytic count values in healthy pregnant women with threatened abortion and the outcome of pregnancy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2023
CompletedStudy Start
First participant enrolled
July 30, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2023
CompletedAugust 14, 2023
August 1, 2023
3 months
July 25, 2023
August 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Highly sensitive CRP (HS-CRP)
A high level of hs-CRP, i.e., greater than 3 mg/L,
9 months
total leucocytic count
measures the number of white blood cells (WBCs) in blood
9 months
Study Arms (2)
Study group
120 healthy women presenting with threatened miscarriage.
Control group
120 healthy women with an uncomplicated single pregnancy.
Interventions
maternal serum high sensitivity C reactive protein
differential leucocytic count levels
Eligibility Criteria
Single intrauterine pregnancy with vaginal hemorrhage and/or abdominal pain in the study group, an ultrasound showing an intrauterine gestational sac with a live fetus and a regular fetal heartbeat, with/without a sub-chorionic hematoma, and healthy women who come for routine antenatal care with spontaneous pregnancy.
You may qualify if:
- Single intrauterine pregnancy with vaginal hemorrhage and/or abdominal pain in the study group,
- an ultrasound showing an intrauterine gestational sac with a live fetus and a regular fetal heartbeat, with/without a sub-chorionic hematoma,
- healthy women who come for routine antenatal care with spontaneous pregnancy.
You may not qualify if:
- Age over 40
- smoking
- multiple pregnancies
- endocrinological diseases
- history of repeated spontaneous abortions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beni-suef university Hospital
Banī Suwayf, Beni Suweif Governorate, 62521, Egypt
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principle investigator/Lecturer of Gynecology and obstetrics Faculty of medicine Beni-Suef University
Study Record Dates
First Submitted
July 25, 2023
First Posted
August 14, 2023
Study Start
July 30, 2023
Primary Completion
October 30, 2023
Study Completion
October 30, 2023
Last Updated
August 14, 2023
Record last verified: 2023-08